COMPANY INTRODUCTION
Inner Mongolia Huaxin Pharmaceutical Co., LTD., hereinafter referred to as Huaxin Pharm, was established in 2019. It is located in Kailu Industrial Park of Kailu , Tongliao, Inner Mongolia Autonomous Region. Huaxin Pharmaceutical covers an area of 120,000m2. It is a veterinary pharmaceutical GMP enterprise integrating research and development, production and sales of sterile veterinary drug API.
The company's main products are Ceftiofur acid, Ceftiofur sodium, Ceftiofur hydrochloride, cefquinome sulfate, amoxicillin sodium, ampicillin sodium and other antibiotic products. In 2023, the company passed the new version of veterinary drug GMP acceptance review and obtained veterinary drug production license. At present, the company has 150 employees, including 10 people with master's degree, 50 people with bachelor's degree, and more than 75% of the total staff are college degree or above .
Huaxin Pharm has the most advanced sterile API clean production workshop, perfect quality management system. We will concentrate on the domestic market, improve market competitiveness, strive to pass the European Union CE certification, and develop overseas markets.
Year of Establishment:
Total Assets(USD):
Total Number of Staff:
Main Competitive Advantages:
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
R&D capacity:
Annual Turnover(USD):
Main Sales Markets:
Other Competitive Advantages:
Patents and Copyrights:
Audited Supplier
Pharma Sources Insight January 2025
